Table 1.
Sociodemographic data and general characteristics of PrEP users in 2020.
| N (%) | ||
|---|---|---|
| Sex | Male | 138 (100) |
| Female | 0 (0) | |
| Mean age (SD) | 33.9 (± 10.1) | |
| Gender of sexual partners | Male | 138 (100) |
| Female | 7 (5.0) | |
| Transgender | 5 (3.6) | |
| School years | 12 or more | 100 (72.5) |
| 10 or 11 | 37 (26.8) | |
| Up to 9 | 1 (0.7) | |
| Profession | Employed (or self-employed) | 89 (64.5) |
| In formation (school/university/training program) | 35 (25.4) | |
| Retired | 5 (3.6) | |
| Unemployed | 6 (4.3) | |
| Other work situation | 3 (2.2) | |
| Income | Own income | 117 (84.8) |
| Financial support during formation by parents/ state /credit | 14 (10.1) | |
| Pension | 3 (2.2) | |
| Unemployment benefit | 3 (2.2) | |
| State income support | 1 (0.7) | |
| Health insurance | Statutory | 132 (95.7) |
| Private | 6 (4.3) | |
| Country of birth | Germany | 119 (86.2) |
| Other EU country | 9 (6.5) | |
| Other non-EU country | 10 (7.2) | |
| Transactional sex (before PrEP initiation) | Has been paid | 4 (2.9) |
| Did pay | 3 (2.2) | |
| PrEP regimen | Daily | 128 (92.8) |
| Intermittent | 9 (6.3) | |
| n/a | 1 (0.7) | |
| Previous HIV chemoprophylaxis | PEP | 11 (7.7) |
| PrEP | 15 (10.4) | |
| Completed vaccinations n (%) | Hepatitis A (2 dosages) | 82 (56.9) |
| Hepatitis B (3 dosages) | 81 (56.3) | |
| Previous STIs | Yes | 86 (62.3) |
SD, standard deviation; STIs, sexually transmitted infections; PEP, post-exposure prophylaxis; PrEP, pre-exposure prophylaxis; n/a, not applicable.